| Dec 31, 2021 | Dec 31, 2022 |
---|
Net loss and comprehensive loss for the period | - | 11 |
---|
Amortization and depreciation | - | 2 |
---|
Share-based compensation | 160,975 | 2 |
---|
Interest expense | - | 36,621 |
---|
Depreciation on right-of-use assets | - | 2 |
---|
Change in lease liabilities due to cash payments | - | -496,835 |
---|
Gain on change in fair value of warrants | 10 | -21,010,500 |
---|
Realized foreign exchange loss | - | -45,465 |
---|
Total operating activities | - | -28,902,494 |
---|
Accounts receivable | - | 3 |
---|
Prepaid expenses | - | 10 |
---|
Accounts payable and accrued liabilities | - | 8 |
---|
Deferred revenue | - | 1 |
---|
Total changes in non-cash working capital | - | -32,331,422 |
---|
Purchase of capital assets | - | 9 |
---|
Purchase of intellectual property | - | 494,769 |
---|
Purchase of marketable securities | - | 1 |
---|
Total investing activities | -300,000,000 | -10,139,167 |
---|
Proceeds from other liabilities | - | 250,000 |
---|
Proceeds from Qualifying Transaction | - | 400 |
---|
Repurchase of Class C Common Stock | - | 11 |
---|
Repayment of Sponsor loan in connection with Qualifying Transaction | - | 2 |
---|
Share issuance costs | - | 54 |
---|
Total financing activities | 300 | 333 |
---|
Increase in cash and cash equivalents during the period | - | 290 |
---|
Cash paid for interest | - | 54 |
---|
Cash paid for lease liabilities | - | 491,210 |
---|